We are live on ! Find out more
Parallel Advisors

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+1.33%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$1.17B
AUM Growth
+$143M
Cap. Flow
+$136M
Cap. Flow %
11.66%
Top 10 Hldgs %
31.87%
Holding
2,617
New
250
Increased
1,039
Reduced
472
Closed
173
Avg Time Held Equity + Options
1.9 years
Top 10 Avg Time Held Equity + Options
1.4 years
Top 20 Avg Time Held Equity + Options
1.6 years
Avg Time Held Equity only
1.9 years
Top 10 Avg Time Held Equity only
1.4 years
Top 20 Avg Time Held Equity only
1.6 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 57.49%
2 Technology 12.25%
3 Financials 6.11%
4 Healthcare 5.77%
5 Communication Services 4.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
WTI icon
2326
W&T Offshore
WTI
$552M
$1K ﹤0.01%
190
– –
2019 Q2
1 quarter
WVVI icon
2327
Willamette Valley Vineyards
WVVI
$10.5M
$1K ﹤0.01%
200
– –
2016 Q4
11 quarters
XME icon
2328
State Street SPDR S&P Metals & Mining ETF
XME
$4.02B
$1K ﹤0.01%
+32
New +$856
2019 Q3
0 quarters
ZTO icon
2329
ZTO Express
ZTO
$15B
$1K ﹤0.01%
66
-490
-88% -$9.85K
2018 Q3
4 quarters
LGF.B
2330
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$1K ﹤0.01%
71
-30
-30% -$322
2017 Q1
10 quarters
INFN icon
2331
DELISTED
Infinera Corporation Common Stock
INFN
$1K ﹤0.01%
251
– –
2018 Q4
3 quarters
TWOU icon
2332
DELISTED
2U Inc
TWOU
$1K ﹤0.01%
+3
New +$2.15K
2019 Q3
0 quarters
NBSE icon
2333
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$1K ﹤0.01%
+6
New +$592
2019 Q3
0 quarters
NSTG
2334
DELISTED
NanoString Technologies, Inc.
NSTG
$1K ﹤0.01%
48
-615
-93% -$16.3K
2019 Q2
1 quarter
ARAV
2335
DELISTED
Aravive, Inc. Common Stock
ARAV
$1K ﹤0.01%
125
– –
2018 Q4
3 quarters
ONCT icon
2336
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$1K ﹤0.01%
14
– –
2016 Q4
11 quarters
HT
2337
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$1K ﹤0.01%
40
– –
2017 Q1
10 quarters
ICPT
2338
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$1K ﹤0.01%
22
– –
2018 Q1
6 quarters
TRHC
2339
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$1K ﹤0.01%
+11
New +$630
2019 Q3
0 quarters
HEXO
2340
DELISTED
HEXO Corp. Common Shares
HEXO
$1K ﹤0.01%
7
-11
-61% -$2.74K
2019 Q2
1 quarter
BSMX
2341
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
$1K ﹤0.01%
199
-519
-72% -$3.56K
2019 Q1
2 quarters
MAXR
2342
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$1K ﹤0.01%
170
– –
2019 Q2
1 quarter
SRNE
2343
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$1K ﹤0.01%
+500
New +$1.17K
2019 Q3
0 quarters
IVC
2344
DELISTED
Invacare Corporation
IVC
$1K ﹤0.01%
162
-1,524
-90% -$8.55K
2019 Q1
2 quarters
CFMS
2345
DELISTED
Conformis, Inc. Common Stock
CFMS
$1K ﹤0.01%
14
– –
2019 Q2
1 quarter
CVET
2346
DELISTED
Covetrus, Inc. Common Stock
CVET
$1K ﹤0.01%
74
– –
2019 Q2
1 quarter
TLND
2347
DELISTED
Talend S.A. American Depositary Shares
TLND
$1K ﹤0.01%
+34
New +$1.26K
2019 Q3
0 quarters
APHA
2348
DELISTED
Aphria Inc. Common Shares
APHA
$1K ﹤0.01%
+200
New +$1.27K
2019 Q3
0 quarters
GLUU
2349
DELISTED
Glu Mobile Inc.
GLUU
$1K ﹤0.01%
137
– –
2019 Q2
1 quarter
FPRX
2350
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$1K ﹤0.01%
+282
New +$1.55K
2019 Q3
0 quarters

Similar funds

Parallel Advisors's Q3 2019 Portfolio in Review

As of Q3 2019, Parallel Advisors held 2,617 positions worth $1.17B, up 14% from $1.03B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Parallel Advisors deployed $136M of net new capital in Q3 2019, opening 250 new positions and adding to 1,039 existing holdings. Its largest new stake was Corteva: 22,483 shares worth $630K.

By sector, the portfolio is most concentrated in Miscellaneous at 57% of assets, up from 56% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $2.83M trimmed.

  • Parallel Advisors's largest Q3 2019 buy was Corteva: 22,483 shares worth $630K.
  • Parallel Advisors added most to iShares MSCI USA Min Vol Factor ETF in Q3 2019, an estimated $16.4M increase.
  • Parallel Advisors's biggest Q3 2019 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $2.83M.
  • Parallel Advisors fully exited Worldpay, Inc. in Q3 2019, selling an estimated $1.07M.
  • Parallel Advisors's ten largest holdings make up 32% of its $1.17B portfolio in Q3 2019.
  • Parallel Advisors opened 250 new positions and closed 173 in Q3 2019.
  • Parallel Advisors's portfolio value rose 14% quarter-over-quarter to $1.17B.

Based on Parallel Advisors's 13F filing for Q3 2019, filed 1 Nov 2019.